Phase 1TerminatedINTERVENTIONAL
Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion
ClinicalTrials.gov · NCT02231658 · Registry updated: 2018-10-17
- Condition / research focus
- Diabetes Mellitus
- Sponsor
- Profil Institut für Stoffwechselforschung GmbH
- Countries with listed sites
- Germany
- Registry dates and results
- Start: 2015-07-16. Completion: 2018-07-23 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Liraglutide (drug)
- Lixisenatide (drug)
Where the study takes place — 2 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- St. Josef-Hospital, Universitätsklinik
Bochum, Germany
Site recruitment: Not reported - Profil Institut für Stoffwechselforschung GmbH
Neuss, Germany
Site recruitment: Not reported